Cytarabine-d2

• CAT Number: S000131
• CAS Number: 40632-26-6
• Molecular Formula: C9H11D2N3O5
• Molecular Weight: 245.23
• Purity: ≥95%
• Target: Anti-infection
• IUPAC Name: 5,6-dideuterio-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-iminopyrimidin-2-one
• InChI: InChI=1S/C9H13N3O5/c10-5-1-2-12(9(16)11-5)8-7(15)6(14)4(3-13)17-8/h1-2,4,6-8,13-15H,3H2,(H2,10,11,16)/t4-,6-,7+,8-/m1/s1/i1D,2D
• InChIKey: UHDGCWIWMRVCDJ-RPTLDJJYSA-N
• SMILES: [2H]C1=C(N(C(=O)NC1=N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O)[2H]

Cytarabine-d2 (CAS: 40632-26-6), a high-quality pharmaceutical research compound designed for advanced oncology and antiviral studies. As a deuterated analog of Cytarabine, it offers enhanced stability and improved pharmacokinetic properties. Cytarabine-d2 is ideal for use in pharmacological and biochemical research, providing precise and reliable data for your studies. This high-purity compound ensures consistent results, aiding in the development of novel therapies for leukemia and viral infections. Trusted by leading laboratories, Cytarabine-d2 is your go-to solution for cutting-edge cancer and antiviral research. Unlock new possibilities in leukemia and antiviral treatment with Cytarabine-d2, where innovation meets reliability.